Guizhou Bailing Group Pharmaceutical Co Ltd Capital Reinvestment Ratio
Guizhou Bailing Group Pharmaceutical Co Ltd capital reinvestment ratio. Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥294.76 Million) in capital expenditures (CN¥3.59 Million). Check how aggressively does Guizhou Bailing Group Pharmaceutical Co reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Guizhou Bailing Group Pharmaceutical Co Ltd (2009–2025)
Capital reinvestment ratio of Guizhou Bailing Group Pharmaceutical Co Ltd from 2009 to 2025. This chart tracks Guizhou Bailing Group Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 15 annual periods. Also explore net asset growth rate of Guizhou Bailing Group Pharmaceutical Co to track the company's year-over-year net asset growth rate.
Guizhou Bailing Group Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2009–2025)
Guizhou Bailing Group Pharmaceutical Co Ltd capital reinvestment ratio by year from 2009 to 2025. For the full cash flow conversion analysis, see Guizhou Bailing Group Pharmaceutical Co cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | CN¥748.72 Million | CN¥125.24 Million | ▼ -96.4% |
| 2024 | 4.66x | CN¥9.02 Million | CN¥42.02 Million | ▲ +462.6% |
| 2023 | 0.83x | CN¥125.77 Million | CN¥104.12 Million | ▲ +507.3% |
| 2022 | 0.14x | CN¥502.15 Million | CN¥68.45 Million | ▼ -89.6% |
| 2021 | 1.31x | CN¥324.92 Million | CN¥425.73 Million | ▲ +237.3% |
| 2020 | 0.39x | CN¥231.78 Million | CN¥90.02 Million | ▲ +48.9% |
| 2019 | 0.26x | CN¥467.41 Million | CN¥121.91 Million | ▼ -85.6% |
| 2017 | 1.81x | CN¥79.88 Million | CN¥144.68 Million | ▲ +430.4% |
| 2016 | 0.34x | CN¥466.62 Million | CN¥159.34 Million | ▲ +16.6% |
| 2015 | 0.29x | CN¥413.23 Million | CN¥121.04 Million | ▲ +20.2% |
| 2014 | 0.24x | CN¥395.83 Million | CN¥96.49 Million | ▼ -61.1% |
| 2013 | 0.63x | CN¥141.76 Million | CN¥88.74 Million | ▼ -93.2% |
| 2012 | 9.23x | CN¥19.52 Million | CN¥180.16 Million | ▲ +865.3% |
| 2011 | 0.96x | CN¥201.90 Million | CN¥193.07 Million | ▲ +446.8% |
| 2009 | 0.17x | CN¥125.31 Million | CN¥21.91 Million | — |